Ovarian cancer (National Institute for Health and Care Excellence (Great Britain)) / National Institute for Health and Care Excellence (NICE).

Format:

Book

Author/Creator:

National Institute for Health and Care Excellence (NICE), author.

Series:

NICE clinical guidelines ; no. 241.

NICE clinical guidelines ; no. 241

Language:

English

Subjects (All):

Genetic screening.

Physical Description:

1 online resource.

Other Title:

Ovarian cancer

Place of Publication:

London : National Institute for Health and Care Excellence (NICE), 2024.

Summary:

This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults. In women, trans men and non-binary people with female reproductive organs (ovaries, fallopian tubes and/or a uterus), having a pathogenic variant increases the risk of developing ovarian cancer (familial ovarian cancer). As well as risk assessment, this guideline covers risk management and decision-making support for people born with female reproductive organs who have, or are at risk of having, a pathogenic variant associated with ovarian cancer. Men, trans women and non-binary people born with male reproductive organs cannot develop ovarian cancer, but if they have a pathogenic variant associated with ovarian cancer, they can pass the variant on to their children, and may be at risk of developing other cancers. This guideline covers risk assessment, but it does not cover managing risk or decision-making support for people born with male reproductive organs.

Contents:

Overview

Recommendations

Recommendations for research

Rationale and impact

Context

Finding more information and committee details.

Notes:

Description based on publisher supplied metadata and other sources.